Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-10-009213
Filing Date
2010-11-04
Accepted
2010-11-04 14:58:02
Documents
12
Period of Report
2010-09-25

Document Format Files

Seq Description Document Type Size
1 10-Q a2200779z10-q.htm 10-Q 777699
2 EX-10.1 a2200779zex-10_1.htm EX-10.1 185004
3 EX-31.1 a2200779zex-31_1.htm EX-31.1 8356
4 EX-31.2 a2200779zex-31_2.htm EX-31.2 8423
5 EX-32.1 a2200779zex-32_1.htm EX-32.1 5507
12 G172523KG01I001.GIF g172523kg01i001.gif GRAPHIC 2623
  Complete submission text file 0001047469-10-009213.txt   4360304

Data Files

Seq Description Document Type Size
6 EX-101.INS crl-20100925.xml EX-101.INS 629626
7 EX-101.SCH crl-20100925.xsd EX-101.SCH 20011
8 EX-101.CAL crl-20100925_cal.xml EX-101.CAL 54846
9 EX-101.DEF crl-20100925_def.xml EX-101.DEF 100094
10 EX-101.LAB crl-20100925_lab.xml EX-101.LAB 288865
11 EX-101.PRE crl-20100925_pre.xml EX-101.PRE 142830
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 261 BALLARDVALE STREET WILMINGTON MA 01867 9786586000
CHARLES RIVER LABORATORIES INTERNATIONAL INC (Filer) CIK: 0001100682 (see all company filings)

EIN.: 061397316 | Fiscal Year End: 1227
Type: 10-Q | Act: 34 | File No.: 001-15943 | Film No.: 101164582
SIC: 8731 Services-Commercial Physical & Biological Research